Rowlandmiller & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
21,008
+450
+2% +$36.3K 0.3% 70
2026
Q1
$1.78M Sell
20,558
-1,585
-7% -$152K 0.36% 60
2025
Q4
$2.13M Sell
22,143
-490
-2% -$47.6K 0.41% 56
2025
Q3
$2.16M Buy
22,633
+5,512
+32% +$507K 0.42% 55
2025
Q2
$1.49M Buy
17,121
+1,285
+8% +$109K 0.31% 66
2025
Q1
$1.42M Buy
15,836
+2,890
+22% +$259K 0.3% 70
2024
Q4
$1.03M Buy
12,946
+320
+3% +$27.7K 0.22% 80
2024
Q3
$1.14M Sell
12,626
-830
-6% -$69.8K 0.23% 79
2024
Q2
$1.06M Buy
13,456
+6,908
+105% +$566K 0.23% 77
2024
Q1
$571K Hold
6,548
0.12% 90
2023
Q4
$539K Hold
6,548
0.12% 90
2023
Q3
$513K Buy
6,548
+310
+5% +$26K 0.13% 94
2023
Q2
$550K Buy
6,238
+757
+14% +$65.2K 0.13% 95
2023
Q1
$442K Buy
5,481
+1,420
+35% +$116K 0.11% 106
2022
Q4
$318K Hold
4,061
0.08% 120
2022
Q3
$328K Hold
4,061
0.09% 113
2022
Q2
$364K Buy
4,061
+217
+6% +$22K 0.09% 106
2022
Q1
$426K Buy
3,844
+401
+12% +$42.4K 0.1% 102
2021
Q4
$356K Buy
+3,443
New +$399K 0.08% 120
2021
Q3
Sell
-2,713
Closed -$337K 169
2021
Q2
$337K Buy
2,713
+1,320
+95% +$166K 0.08% 116
2021
Q1
$165K Buy
+1,393
New +$163K 0.04% 143

Other funds holding MDT

Rowlandmiller & Partners's MDT Position: Q2 2026 in Review

Rowlandmiller & Partners increased its Medtronic (MDT) stake by 2.2% in Q2 2026, buying an estimated $36.3K and bringing the position to 21,008 shares worth $1.64M. The position accounts for 0.3% of the portfolio, ranked #70.

Rowlandmiller & Partners first reported a position in MDT in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.16M in Q3 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Rowlandmiller & Partners held 21,008 shares of Medtronic worth $1.64M as of Q2 2026.
  • Rowlandmiller & Partners bought 450 Medtronic shares in Q2 2026, an estimated $36.3K.
  • Medtronic made up 0.3% of Rowlandmiller & Partners's portfolio in Q2 2026, its #70 holding.
  • Rowlandmiller & Partners first reported a position in Medtronic in Q1 2021 and has held it in 21 quarters since.
  • Rowlandmiller & Partners's Medtronic position peaked at $2.16M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.